Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Akt
    (23)
  • ROCK
    (5)
  • PKA
    (4)
  • PKC
    (4)
  • PROTACs
    (4)
  • S6 Kinase
    (4)
  • Autophagy
    (3)
  • Apoptosis
    (2)
  • mTOR
    (2)
  • Others
    (14)
Filter
Search Result
Results for "

Akt3

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    44
    TargetMol | Inhibitors_Agonists
  • PROTAC Products
    8
    TargetMol | PROTAC
  • Recombinant Protein
    5
    TargetMol | Recombinant_Protein
  • Antibody Products
    3
    TargetMol | Antibody_Products
Akt3 degrader 1
T749822836342-69-7In house
Akt3 degrader 1 is a specific Akt3 degrader with anticancer and antiproliferative activity that inhibits tumor growth in mice.Akt3 degrader 1 is used in the study of non-small cell lung cancer and pancreatic cancer.
  • Inquiry Price
Size
QTY
Capivasertib
AZD5363
T19201143532-39-1
Capivasertib (AZD5363) is a broad-spectrum AKT inhibitor with inhibitory activity against Akt1, Akt2, and Akt3 (IC50=3 7 7 nM) with oral activity. Capivasertib has antitumor activity for the treatment of breast cancer.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
MK-2206 dihydrochloride
MK-2206 2HCl
T19521032350-13-2
MK-2206 dihydrochloride (MK-2206 2HCl) is a variant Akt inhibitor that inhibits Akt1, Akt2, and Akt3 (IC50=8 12 65 nM) with orally active, highly potent and selective potency. MK-2206 dihydrochloride exhibits antitumor activity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Afuresertib
GSK2110183C, GSK2110183
T19111047644-62-1
Afuresertib (GSK2110183) is an orally bioavailable inhibitor of the serine threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
AKT inhibitor VIII
AKTi-1 2
T3346612847-09-3
AKT inhibitor VIII (AKTi-1 2) is a highly specific inhibitor of Akt1 2, with IC50 values of 58 nM and 210 nM respectively, demonstrating approximately 36-fold greater selectivity for Akt1 over Akt3.
  • Inquiry Price
Size
QTY
Ipatasertib
RG7440, GDC-0068
T62521001264-89-6
Ipatasertib (GDC-0068) is a selective, ATP-competitive pan-Akt inhibitor that inhibits Akt1 (IC50:5 nM), Akt2 (IC50:18 nM), and Akt3 (IC50:8 nM). Ipatasertib (GDC-0068) can lead to p53-independent PUMA activation by inhibiting Akt, thereby activating FoxO3a and NF-κB simultaneously, directly binding to the PUMA promoter, upregulating PUMA transcription and Bax-mediated intrinsic mitochondrial apoptosis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
GSK-690693
GSK690693
T6285937174-76-0
GSK-690693 is a pan-Akt inhibitor targeting Akt1 2 3 with IC50 of 2 nM 13 nM 9 nM, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. Phase 1.
  • Inquiry Price
Size
QTY
Uprosertib
GSK795, GSK2141795
T68491047634-65-0
Uprosertib (GSK2141795) is a potent, selective Akt broad-spectrum inhibitor with IC50 values of 180 328 38 nM for Akt1 Akt2 Akt3.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
A-443654
T14072552325-16-3
A-443654, a pan-Akt inhibitor, exhibits equal potency against Akt1, Akt2, and Akt3 within cells (Ki=160 pM).
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
AT13148
T24821056901-62-2
AT13148 is an oral-active and ATP-competitive, multi-AGC kinase inhibitor for Akt1 2 3, p70S6K, PKA, and ROCKI II.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
AT7867
T6304857531-00-1
AT7867 is a potent ATP-competitive inhibitor of Akt1 2 3 and p70S6K PKA with IC50 values of 32 nM, 17 nM, 47 nM, 85 nM, and 20 nM, respectively, exhibiting little activity outside the AGC kinase family.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
akt kinase inhibitor
T10276842148-40-7In house
AKT Kinase Inhibitor is an Akt inhibitor with antitumor activity that selectively inhibits cell proliferation in a dose-dependent manner.
  • Inquiry Price
10-14 weeks
Size
QTY
TargetMol | Inhibitor Hot
Hu7691 free base
T397332241232-43-7In house
Hu7691 free base is an orally active, potent, and selective Akt inhibitor with anti-proliferative and neurogenic effects on various neuroblastoma cell lines. It inhibits Akt1, Akt2, and Akt3, and induces differentiation of neuroblastoma cells.
  • Inquiry Price
Size
QTY
Hu7691
T398992360523-76-6In house
Hu7691 is an orally active, selective, and potent Akt inhibitor that targets Akt1, Akt2, and Akt3, while also inhibiting neuroblastoma cell proliferation and inducing their differentiation.
  • Inquiry Price
1-2 weeks
Size
QTY
MS170
T399282376136-61-5In house
MS170 is a highly effective and specific PROTAC AKT degrader compound that exhibits potent activity. It efficiently reduces the levels of total AKT (T-AKT) within cells, with a DC 50 value of 32 nM. Furthermore, MS170 demonstrates strong binding affinity towards AKT isoforms, specifically AKT1, AKT2, and AKT3, with respective dissociation constants (Kd) of 1.3 nM, 77 nM, and 6.5 nM.This compound is unstable in powder form and other related salt forms are recommended.
  • Inquiry Price
3-6 months
Size
QTY
Miransertib
ARQ-092, AKT inhibitor 2
T34671313881-70-7
Miransertib (ARQ-092) is an orally bioavailable, selective, and potent allosteric Akt inhibitor.
  • Inquiry Price
Size
QTY
GSK269962A
GSK269962B, GSK269962A HCl, GSK 269962
T3518850664-21-0
GSK269962A (GSK269962A HCl) is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.
  • Inquiry Price
Size
QTY
mk-2206
MK-2206 Monohydrochloride
T626091032349-77-1
MK-2206 is an orally active, highly selective, metabotropic Akt inhibitor that targets Akt1 [IC50: 8 nM], Akt2 [IC50: 12 nM], and Akt3 [IC50: 65 nM]. Many breast cancer cell lines, PIK3CA mutants, and PTEN-losing cell lines are sensitive to MK-2206, which exhibits anti-cancer effects.
  • Inquiry Price
1-2 weeks
Size
QTY
(+)-Tetrabenazine
(+)-TBZ, (3R,11bR)-Tetrabenazine, (3R,11bR)-TBZ
T131341026016-83-0
(+)-Tetrabenazine ((3R,11bR)-Tetrabenazine) is a reversible vesicular monoamine transporter 2 (VMAT-2) inhibitor, inhibits transport by VMAT2 with 10-fold greater potency than transport by VMAT1.
  • Inquiry Price
10-14 weeks
Size
QTY
TargetMol | Inhibitor Sale
AKT-IN-3
T102752374740-21-1
AKT-IN-3 is a potent, orally active low hERG blocking Akt inhibitor (IC50: 1.4 nM, 1.2 nM, and 1.7 nM for Akt1, Akt2, and Akt3). AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kinases, such as PKA, PKC, ROCK1, RSK1
  • Inquiry Price
3-6 months
Size
QTY
INY-03-041
T11664
INY-03-041, a potent and highly selective PROTAC-based pan-AKT degrader, inhibits AKT1, AKT2, and AKT3 with IC50s of 2.0 nM, 6.8 nM, and 3.5 nM, respectively. This compound consists of the ATP-competitive AKT inhibitor GDC-0068 conjugated to Lenalidomide.
  • Inquiry Price
Size
QTY
M2698
MSC2363318A
T119281379545-95-5
M2698 (MSC2363318A) is an inhibitor of p70S6K, Akt1 and Akt3 with IC50s of 1 nM. M2698 shows anti-cancer activity.
  • Inquiry Price
8-10 weeks
Size
QTY
Uprosertib hydrochloride
GSK2141795 (hydrochloride)
T154281047635-80-2
Uprosertib hydrochloride is a potent and selective inhibitor of pan-Akt (IC50: 180 328 38 nM for Akt1 Akt2 Akt3, respectively).
  • Inquiry Price
1-2 weeks
Size
QTY
9-Decyn-1-ol
T1734617643-36-6
9-Decyn-1-ol is an alkyl ether-based PROTAC linker used in synthesizing PROTACs, acting as a conjugation agent to combine GDC-0068 and Lenalidomide to form INY-03-041. INY-03-041 is a potent and highly selective pan-Akt degrader that inhibits Akt1, Akt2, and Akt3 with IC50 values of 2.0 nM, 6.8 nM, and 3.5 nM, respectively[1].
  • Inquiry Price
7-10 days
Size
QTY